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Though rare, renal transplantation into a bowel containing urinary diversion is necessary in select clinical
situations. Compared to renal transplant patients with functional native bladders, patients with urinary
diversion have comparable long-term graft and patient survival rates. However, compounding the
increased risk of malignancy in those on chronic immunosuppression are the inherent risks of urinary
diversion. We present a case report of a high grade adenocarcinoma with neuroendocrine differentiation
arising in an ileal conduit and discussion on the pathophysiology, management, and screening of this
highly select population.
 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Background
Renal transplantation into a bowel containing urinary diver-
sion is necessary in select clinical situations. It is estimated that
roughly 15% of patients with end-stage renal disease will have
some structural abnormality of the lower urinary tract causing
dysfunction, with some requiring urinary diversion.1 Large single
institution studies have shown that long-term graft and patient
survival rates are comparable in renal transplant patients with
urinary diversion to those with functional native bladders.2
Regardless, bowel containing urinary diversions have known
short and long term complications and solid organ transplants
carry an increased risk of malignancy due to chronic immuno-
suppression.We present a case of a rare adenocarcinoma arising in
a bowel containing urinary diversion draining a transplanted renal
allograft.Case report
The patient is a 47 year old male with a history of ileal conduit
urinary diversion in 1978 and renal transplantation (on.edu (R.S. Matulewicz).
Inc. This is an open access article uazathioprine, prednisone) in 1980. His genitourinary abnormal-
ities and end-stage renal disease were presumed to be congenital
in origin secondary to posterior urethral valves, although no
records were available. He ﬁrst presented at our institution in June
of 2009 with obstruction of the ileal conduit approximately 2.5 cm
proximal to the stoma site (Fig. 1) and Pseudomonas aeruginosa
pyelonephritis. He was treated with a percutaneous nephrostomy
tube for maximal decompression and antibiotics. Subsequent
dilation of the conduit stricture and placement of a single-J ure-
teral stent were unsuccessful secondary to early recurrence of the
stricture. Deﬁnitive treatment with exploration and revision of his
conduit were undertaken, which was complicated by signiﬁcant
and extensive scarring around the kidney and conduit. Intra-
operatively a solid mass was discovered at the stricture site and
was resected along with a limited lymph node dissection. The ﬁnal
pathologic diagnosis was high-grade adenocarcinoma with
neuroendocrine features, positive margins, and all three lymph
nodes negative (Fig. 2).
Follow up PET scans revealed increased uptake around the
conduit area shortly after surgery. Subsequent surveillance PET
scans demonstrated the development of multiple liver lesions
consistent withmetastasis, as well as soft tissue nodules adjacent to
the prior surgical site and the abdominal wall. The patient was
started on chemotherapy, but progressed on two different regimens
until he entered hospice care and passed away roughly 2 years after
his initial presentation at our institution.nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Representative coronal and axial images of stricture seen in ileal conduit on the patient’s initial presentation. The images are notable for signiﬁcant dilatation of the
proximal aspect of the conduit and moderate hydronephrosis of the transplant kidney. White arrow depicts area of narrowing seen in both planes.
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Fewer than 100 cases of new primary malignancy in a urinary
diversion using isolated bowel segments have been reported in the
literature. In ileal conduits speciﬁcally, only twelve cases have been
reported, three of which were adenocarcinomas and two were
carcinoid tumors.3 Notably, none of these were in the setting of
prior renal transplantation. To date, using an Ovid-Medline search,
no report of a poorly differentiated neuroendocrine tumor arising in
a urinary diversion has been described.
The exact mechanism of carcinogenesis in urinary diversions is
unclear, but it is likely multi-factorial. Several animal studies have
shown the carcinogenic effect of urine on intestinal mucosa due to
the chronic stasis of urinary bacteria, especially gram-negative
bacteria that are able to form N-nitrosamines.4 This, in addition to
the known pro-inﬂammatory reaction formed by even sterile urine
on intestinal epithelium, may explain the oncologic potential in
these intestinal segments. This patient was a short-term smoker (5
pack years, quit 4 years prior to presentation) with no occupational/
environmental exposures or personal risk factors known to beassociated with malignant changes to the urothelium or bowel.
Importantly, he had no personal or family history of Crohn’s dis-
ease, celiac disease, or familial adenomatous polyposis syndrome.
In the transplanted population however, chronic immunosup-
pression is a known risk factor for the development of any malig-
nancy and the overall incidence of cancer after renal
transplantation is considerably higher than the general population.
The proper screening protocol for post-renal transplant patients
has not yet been elucidated as limited data exists for this popula-
tion. Proper screening can be inferred based on evidence based
standards in both the bladder cancer population and for small
bowel malignancy. Combining these principles with a high clinical
suspicion for this atypical presentation will aid in earlier diagnosis.
No standard screening protocols are available for primary small
bowel cancers, but an early warning sign is a positive fecal occult
blood test. Therefore, microhematuria in a post-transplant patient
with a urinary diversion should not be ignored. In post-cystectomy
patients for bladder cancer, the NCCN guidelines suggest a urine
cytology test every 3 months, alongside axial imaging in the initial
2 year post-operative period with the goal of detecting upper tract
Figure 2. Adenocarcinoma with neuroendocrine differentiation (grade 3) of the ileal conduit inﬁltrating the lamina propria (A) and muscularis propria. The tumor shows glandular
differentiation and high mitotic activity (B). The tumor cells are positive for chromogranin (C) and synaptophysin (D).
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lance protocol would be minimally invasive, but repeated contrast
administration could potentially threaten the transplant allograft. It
should be noted that it would be less necessary to screen for upper
tract urothelial carcinoma in patients without a history of bladder
cancer, as in this population.
There are differences in the timing of surgical complications
seen with anastamotic strictures versus conduit strictures. This
timing difference could help differentiate whether there is a tech-
nical issue (early stricture at anastomosis) or something more
concerning like a cancer recurrence (in conduit). In a large series
with long-term follow up a rate of anastamotic stricture was seen
roughly 10% of the time at a median of 1.1 years. Conduit stricture
was much less common, occurring 2.4% of the time at a median of
9.4 years.5
Clinical suspicion must be high in patients presenting with
worsening hydronephrosis, hematuria, or recurrent UTIs. Although
no evidence based screening regimen is available, the authors
suggest a combination of urinalysis to check for microhematuria,
urine cytology, axial imaging, and direct visual surveillance with
looposcopy or loopogram to follow these patients.Disclosures
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